# ANGIOTENSIN ll ACETATE
> **ANDA216966** · Abbreviated New Drug Application (Generic) · Sponsor: GLAND · Approved 2025-06-03
## Drug
- **FDA Application Number:** ANDA216966
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ANGIOTENSIN ll ACETATE
- **Generic name:** ANGIOTENSIN II
- **Active ingredients:** ANGIOTENSIN II ACETATE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** GLAND
- **Manufacturer:** Gland Pharma Limited
- **First approval:** 2025-06-03
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216966)
---
*AI Analytics · CC0 1.0*